BDBM50162975 4-(3H-Benzoimidazol-5-ylamino)-6-(1-methyl-1-phenyl-ethylamino)-[1,3,5]triazin-2-ol::CHEMBL175830

SMILES CC(C)(Nc1nc(Nc2ccc3nc[nH]c3c2)[nH]c(=O)n1)c1ccccc1

InChI Key InChIKey=BIAXZMJEGJLELQ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50162975   

TargetVascular endothelial growth factor receptor 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162975(4-(3H-Benzoimidazol-5-ylamino)-6-(1-methyl-1-pheny...)
Affinity DataIC50: 240nMAssay Description:In vitro inhibition of Vascular endothelial growth factor receptor 2 at 10 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162975(4-(3H-Benzoimidazol-5-ylamino)-6-(1-methyl-1-pheny...)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibition of Vascular endothelial growth factor receptor 2 at 10 uM ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed